Trading Nvidia earnings report? These are the entry and exit levels to watch for
Investing.com-- Warren Buffet’s Berkshire Hathaway Inc (NYSE:BRKa) said on Wednesday that it had sold another 750,000 shares in kidney dialysis service provider DaVita HealthCare (NYSE:DVA), trimming its stake further in the company.
The sales occurred between February 14 and 19 and were worth about $115 million, a filing showed on Wednesday evening. The sales reduced Berkshire’s stake in DaVita to about 35.1 million shares worth more than $5 billion.
The new sales came just a week after Berkshire disclosed a 203,091 share sale in DaVita, which was part of a repurchase agreement. It was not immediately clear what the purpose of the new sale was.
DaVita’s shares had slumped 11% after last week’s sale.
DaVita is one of Berkshire’s biggest holdings, with the hedge fund having held a stake in the company since 2011.